Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Valeo Pharma Inc T.VPH

Alternate Symbol(s):  T.VPH.DB | VPHIF

Healthcare
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler,... see more

Bullboard (TSX:VPH)

View:
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next
Post by Betteryear2on Jan 29, 2024 5:59pm

Fourth Quarter and year-end 2023 Webcast and Conference Call

Valeo will host a conference call to discuss its fourth quarter and year-end 2023 results and highlights on Tuesday January 30, 2024, at 8.30 am (ET). The telephone numbers to access the ...more  
95
Post by Betteryear2on Jan 29, 2024 5:57pm

VALEO PHARMA REPORTS RECORD ANNUAL REVENUES

Record revenues of $54 million for fiscal 2023, up 94% over 2022 Revenues of $13.1 million for Q4-23, up 4% over Q4-22 Record annual adjusted gross profit of $16.9 ...more  
114
Post by Bluechips19on Nov 22, 2023 11:52pm

VPH

Interesting opportunityi high revenue high expenses. See where this sits next spring could be a nice play here at these levels
177
Post by Betteryear2on Jul 04, 2023 6:04pm

UPDATE ON OPHTHALMOLOGY BUSINESS UNIT T.VPH

Novartis agrees to sell global rights to XIIDRA® and several other ophthalmology products to Baucsh + Lomb SIMBRINZA® not included in the divestiture MONTREAL, July 4, 2023  ...more  
320
Post by NonoRobotSGon Jun 15, 2023 11:19am

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES

VALEO PHARMA REPORTS RECORD SECOND QUARTER REVENUES - Valeo Pharma
166
Post by Royal10on Jun 06, 2023 3:55pm

VPH: To profit from forest fires!

VPH sells products with a focus on Respiratory/Allergy.
170
Post by Royal10on Mar 15, 2023 10:44am

VPH: ECHELON's target price: $1.00!

Valeo Pharma trades at 55 cents today. The co will report its Q1/23 results after the close today! I am very anxious to see these results! Some analysts expect  a loss of $0.09 ! We never know .. ...more  
314
Comment by Royal10on Nov 15, 2022 1:39pm

RE:VPH: Announces higher revenue guidance for Q4/2022.

Technically , VPH could potentially double in the next few weeks. Simple Moving Avg (30) ——Simple Moving Avg (90) ——
281
Discussion
Post by Royal10on Nov 15, 2022 1:34pm

VPH: Announces higher revenue guidance for Q4/2022.

VALEO PHARMA RAISES Q4 AND FULL YEAR 2022 REVENUE GUIDANCE Valeo Pharma Inc. has raised revenue guidance for its fourth quarter of 2022 to $12.5-million to $13-million, an increase of 14 per cent to ...more  
265
Discussion
Post by bmreedon Sep 26, 2022 1:06pm

Video Recap - $VPH CEO Steve Saviuk and Radius Research

Webinar Recap: Valeo Pharma (VPH) w CEO Steve Saviuk - Pitch, Deep Dive and Q&A - https://youtu.be/ESItGs4uVuk   CEO Steve Saviuk discusses recent Q3 Financials and the new addition of ...more  
292
Post by bmreedon Sep 16, 2022 1:01pm

Webinar w $VPH CEO Steve Saviuk - Tue Sep 20 @ 1:30PM ET

Webinar - Valeo Pharma $VPH w/ CEO Steve Saviuk Tue, September 20 at 1:30pm ET / 10:30am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar/register ...more  
213
Post by TrevorAbeson Aug 02, 2022 5:40pm

Valeo Pharma (TSX:VPH) partners with Novartis

https://themarketherald.ca/valeo-pharma-tsxvph-partners-with-novartis-2022-08-02/
232
Post by vanbmtzon Jun 16, 2022 1:17pm

Commercializing Innovative Prescription Products in Canada

Watch Valeo's presentation shortly. They are up at 10:30am PT / 1:30pm ET.  Here's the link to tune in  
244
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next